BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21269699)

  • 21. Mutation analysis of BEST1 in Japanese patients with Best's vitelliform macular dystrophy.
    Katagiri S; Hayashi T; Ohkuma Y; Sekiryu T; Takeuchi T; Gekka T; Kondo M; Iwata T; Tsuneoka H
    Br J Ophthalmol; 2015 Nov; 99(11):1577-82. PubMed ID: 26201355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clinical Features and Genetic Spectrum of a Large Cohort of Chinese Patients With Vitelliform Macular Dystrophies.
    Xuan Y; Zhang Y; Zong Y; Wang M; Li L; Ye X; Liu W; Chen J; Sun X; Zhang Y; Chen Y
    Am J Ophthalmol; 2020 Aug; 216():69-79. PubMed ID: 32278767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABCA4 and ROM1: implications for modification of the PRPH2-associated macular dystrophy phenotype.
    Poloschek CM; Bach M; Lagrèze WA; Glaus E; Lemke JR; Berger W; Neidhardt J
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4253-65. PubMed ID: 20335603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene.
    Querques G; Zerbib J; Santacroce R; Margaglione M; Delphin N; Rozet JM; Kaplan J; Martinelli D; Delle Noci N; Soubrane G; Souied EH
    Mol Vis; 2009 Dec; 15():2960-72. PubMed ID: 20057903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy.
    Seddon JM; Afshari MA; Sharma S; Bernstein PS; Chong S; Hutchinson A; Petrukhin K; Allikmets R
    Ophthalmology; 2001 Nov; 108(11):2060-7. PubMed ID: 11713080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOVEL BEST1 MUTATIONS DETECTED BY NEXT-GENERATION SEQUENCING IN A CHINESE POPULATION WITH VITELLIFORM MACULAR DYSTROPHY.
    Guo J; Gao F; Tang W; Qi Y; Xuan Y; Liu W; Li L; Ye X; Xu G; Wu J; Zhang Y
    Retina; 2019 Aug; 39(8):1613-1622. PubMed ID: 29781975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in IMPG1 cause vitelliform macular dystrophies.
    Manes G; Meunier I; Avila-Fernández A; Banfi S; Le Meur G; Zanlonghi X; Corton M; Simonelli F; Brabet P; Labesse G; Audo I; Mohand-Said S; Zeitz C; Sahel JA; Weber M; Dollfus H; Dhaenens CM; Allorge D; De Baere E; Koenekoop RK; Kohl S; Cremers FP; Hollyfield JG; Sénéchal A; Hebrard M; Bocquet B; Ayuso García C; Hamel CP
    Am J Hum Genet; 2013 Sep; 93(3):571-8. PubMed ID: 23993198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for BEST1 gene mutations in Chinese patients with bestrophinopathy.
    Tian R; Yang G; Wang J; Chen Y
    Mol Vis; 2014; 20():1594-604. PubMed ID: 25489231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation of BEST1 gene in Best disease.
    Campa C; Parmeggiani F; Spena R; Ognibene D; Passerini I; Gualandi F
    Eur J Ophthalmol; 2021 May; 31(3):NP93-NP95. PubMed ID: 32321300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autosomal recessive vitelliform macular dystrophy in a large cohort of vitelliform macular dystrophy patients.
    Kinnick TR; Mullins RF; Dev S; Leys M; Mackey DA; Kay CN; Lam BL; Fishman GA; Traboulsi E; Iezzi R; Stone EM
    Retina; 2011 Mar; 31(3):581-95. PubMed ID: 21273940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Clinical and Genetic Heterogeneity With BEST1 Sequence Variations.
    Shah M; Broadgate S; Shanks M; Clouston P; Yu J; MacLaren RE; Németh AH; Halford S; Downes SM
    JAMA Ophthalmol; 2020 May; 138(5):544-551. PubMed ID: 32239196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Best's macular dystrophy in Australia: phenotypic profile and identification of novel BEST1 mutations.
    Cohn AC; Turnbull C; Ruddle JB; Guymer RH; Kearns LS; Staffieri S; Daggett HT; Hewitt AW; Mackey DA
    Eye (Lond); 2011 Feb; 25(2):208-17. PubMed ID: 21109774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of two consanguineous families with homozygous mutations in BEST1.
    Piñeiro-Gallego T; Álvarez M; Pereiro I; Campos S; Sharon D; Schatz P; Valverde D
    Mol Vis; 2011; 17():1607-17. PubMed ID: 21738390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene.
    Querques G; Zerbib J; Santacroce R; Margaglione M; Delphin N; Querques L; Rozet JM; Kaplan J; Souied EH
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4678-84. PubMed ID: 21436265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult-Onset Vitelliform Macular Dystrophy caused by BEST1 p.Ile38Ser Mutation is a Mild Form of Best Vitelliform Macular Dystrophy.
    Jun I; Lee JS; Lee JH; Lee CS; Choi SI; Gee HY; Lee MG; Kim EK
    Sci Rep; 2017 Aug; 7(1):9146. PubMed ID: 28831140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel VMD2 mutation in Japanese patients with Best disease.
    Yanagi Y; Sekine H; Mori M
    Ophthalmic Genet; 2002 Jun; 23(2):129-33. PubMed ID: 12187431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of BEST1 Gene in a Chinese Cohort With Best Vitelliform Macular Dystrophy or Autosomal Recessive Bestrophinopathy.
    Tian L; Sun T; Xu K; Zhang X; Peng X; Li Y
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3366-3375. PubMed ID: 28687848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Best Vitelliform Macular Dystrophy Natural History Study Report 1: Clinical Features and Genetic Findings.
    Laich Y; Georgiou M; Fujinami K; Daich Varela M; Fujinami-Yokokawa Y; Hashem SA; Cabral de Guimaraes TA; Mahroo OA; Webster AR; Michaelides M
    Ophthalmology; 2024 Jul; 131(7):845-854. PubMed ID: 38278445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel mutation in BEST1 associated with retinoschisis.
    Silva RA; Berrocal AM; Lam BL; Albini TA
    JAMA Ophthalmol; 2013 Jun; 131(6):794-8. PubMed ID: 23572118
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenotypic variability and long-term follow-up of patients with known and novel PRPH2/RDS gene mutations.
    Renner AB; Fiebig BS; Weber BH; Wissinger B; Andreasson S; Gal A; Cropp E; Kohl S; Kellner U
    Am J Ophthalmol; 2009 Mar; 147(3):518-530.e1. PubMed ID: 19038374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.